Momenta Pharmaceuticals
Why Robinhood?
You can watch MNTA and buy or sell other stocks, ETFs, and their options commission-free!About MNTA
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.
MNTA Key Statistics
Stock Snapshot
As of today, Momenta Pharmaceuticals(MNTA) shares are valued at $52.48. The company's market cap stands at 6.24B, with a P/E ratio of -24.70.
On 2026-03-12, Momenta Pharmaceuticals(MNTA) stock opened at —, reached a high of —, and a low of —.
The Momenta Pharmaceuticals(MNTA)'s current trading volume is 0, compared to an average daily volume of 2.68M.
In the last year, Momenta Pharmaceuticals(MNTA) shares hit a 52-week high of $52.53 and a 52-week low of $12.58.
In the last year, Momenta Pharmaceuticals(MNTA) shares hit a 52-week high of $52.53 and a 52-week low of $12.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.